Six-month incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Mooij, Sofie H ^a,e   Boot, Hein J ^b   Speksnijder, Arjen G C L ^a   Meijer, Chris J L M ^c   King, Audrey J ^b   Verhagen, Dominique W M ^d   De Vries, Henry J C ^a,b,e   Quint, Wim G V ^f   Molijn, Anco ^f   De Koning, Maurits N C ^f   Van Der Sande, Marianne A B ^b,g   Schim Van Der Loeff, Maarten F ^a,e  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Jan Van Goyen Medical Center   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f DDL DIAGNOSTIC LABORATORY   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DNA DETERMINATION; DRUG USE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MOUTH EXAMINATION; MOUTH INFECTION; PAPILLOMAVIRUS INFECTION; RISK ASSESSMENT; SEQUENCE ANALYSIS; SEXUAL BEHAVIOR; ADOLESCENT; COMPLICATION; FEMALE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; INCIDENCE; ISOLATION AND PURIFICATION; MALE HOMOSEXUALITY; MIDDLE AGED; MOUTH DISEASES; NETHERLANDS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOGENICITY; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; TIME; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOUTH DISEASES; NETHERLANDS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84902504723     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098955     Document Type: Article

References (38)

1. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, et al. (2009) A review of human carcinogens-Part B: biological agents. Lancet Oncol 10: 321-322.
2. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, et al. (2006) Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 31: 259-266. (Pubitemid 44141088)
3. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14: 467-475. (Pubitemid 40270113)
4. Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M (2012) Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol 6 Suppl 1: 104-120.
5. Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, et al. (2010) Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2: 15.
6. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, et al. (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29: 4294-4301.
7. Mehanna H, Paleri V, West CM, Nutting C (2010) Head and neck cancer-Part 1: Epidemiology, presentation, and prevention. BMJ 341: c4684.
8. Hocking JS, Stein A, Conway EL, Regan D, Grulich A, et al. (2011) Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104: 886-891.
9. Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, et al. (2012) Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 132:1565-1571.
10. Beachler DC, Weber KM, Margolick JB, Strickler HD, Cranston RD, et al. (2012) Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev 21: 122-133.
11. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML (2009) Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 199: 1263-1269.
12. Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, et al. (2004) Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 189: 686-698. (Pubitemid 38270923)
13. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, et al. (2012) Prevalence of Oral HPV Infection in the United States, 2009-2010. JAMA 307: 693-703.
14. Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, et al. (2010) Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 37: 386-391.
15. Mooij SH, Boot HJ, Speksnijder AG, Stolte IG, Meijer CJ, et al. (2013) Oral human papillomavirus infection in HIV-negative and HIV-infected men who have sex with men: the HIV & HPV in MSM (H2M) study. AIDS 27: 2117-2128.
16. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370: 59-67. (Pubitemid 47017468)
17. Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, et al. (2009) HIV infection and the risk of cancers with and without a known infectious cause. AIDS 23: 2337-2345.
18. Pickard RK, Xiao W, Broutian TR, He X, Gillison ML (2012) The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis 39: 559-566.
19. Edelstein ZR, Schwartz SM, Hawes S, Hughes JP, Feng Q, et al. (2012) Rates and determinants of oral human papillomavirus infection in young men. Sex Transm Dis 39: 860-867.
20. Kreimer AR, Pierce Campbell CM, Lin HY, Fulp W, Papenfuss MR, et al. (2013) Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet 382: 877-887.
21. Jansen IA, Geskus RB, Davidovich U, Jurriaans S, Coutinho RA, et al. (2011) Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study. AIDS 25: 493-501.
22. Heijman RL, Stolte IG, Thiesbrummel HF, van LE, Coutinho RA, et al. (2009) Opting out increases HIV testing in a large sexually transmitted infections outpatient clinic. Sex Transm Infect 85: 249-255.
23. Molijn A, Kleter B, Quint W, Van Doorn LJ (2005) Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 32 Suppl 1: S43-S51. (Pubitemid 40332588)
24. Xue X, Gange SJ, Zhong Y, Burk RD, Minkoff H, et al. (2010) Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev 19: 159-169.
25. Said AK, Leao JC, Fedele S, Porter SR (2013) Focal epithelial hyperplasia - an update. J Oral Pathol Med 42: 435-442.
26. Beachler DC, D'Souza G, Sugar EA, Xiao W, Gillison ML (2013) Natural history of anal versus oral HPV infection in HIV-infected men and women. J Infect Dis 208: 330-339.
27. Louvanto K, Rautava J, Willberg J, Wideman L, Syrjanen K, et al. (2013) Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study. PLoS One 8: e53413.
28. Feller L, Wood NH, Khammissa RA, Lemmer J (2010) Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma. Head Face Med 6: 15.
29. Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH (2010) Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis 10: 862-874.
30. Gravitt PE (2011) The known unknowns of HPV natural history. J Clin Invest 121: 4593-4599.
31. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, et al. (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100: 407-420. (Pubitemid 351480511)
32. Goon PK, Stanley MA, Ebmeyer J, Steinstrasser L, Upile T, et al. (2009) HPV & head and neck cancer: a descriptive update. Head Neck Oncol 1: 36.
33. Bottalico D, Chen Z, Dunne A, Ostoloza J, McKinney S, et al. (2011) The oral cavity contains abundant known and novel human papillomaviruses from the betapapillomavirus and gammapapillomavirus genera. J Infect Dis 204: 787-792.
34. Lang Kuhs KA, Gonzalez P, Struijk L, Castro F, Hildesheim A, et al. (2013) Prevalence of and risk factors for oral human papillomavirus among young women in costa rica. J Infect Dis 208: 1643-1652.
35. Forslund O, Johansson H, Madsen KG, Kofoed K (2013) The nasal mucosa contains a large spectrum of human papillomavirus types from the Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis 208: 1335-1341.
36. Munday JS, Kiupel M, French AF, Howe L, Squires RA (2007) Detection of papillomaviral sequences in feline Bowenoid in situ carcinoma using consensus primers. Vet Dermatol 18: 241-245. (Pubitemid 47140996)
37. Steinau M, Reddy D, Sumbry A, Reznik D, Gunthel CJ, et al. (2012) Oral sampling and human papillomavirus genotyping in HIV-infected patients. J Oral Pathol Med 41: 288-291.
38. Fakhry C, Sugar E, D'Souza G, Gillison M (2010) Two-week versus six-month sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort. PLoS One 5: e11918.